| abstract |
The present disclosure relates to methods for treating viral hepatitis, compounds useful for the treatment of viral hepatitis, and pharmaceutical compositions comprising such compounds. In one embodiment, pharmaceutical compositions comprising nitazoxanide, tizoxanide, or derivatives and / or mixtures thereof, and methods of treating hepatitis C using such compositions are provided. In one embodiment of the invention, the composition may further comprise one or more additional biologically active agents. |